Literature DB >> 15009242

Sequential pathology after initial freshwater bath treatment for amoebic gill disease in cultured Atlantic salmon, Salmo salar L.

M B Adams1, B F Nowak.   

Abstract

Freshwater bathing is essential for control of amoebic gill disease (AGD) during the marine phase of the Tasmanian Atlantic salmon production cycle, a practice that is costly, production limiting and increasing in frequency. Although the pathogenesis of gill infection with Neoparamoeba sp. in naïve Atlantic salmon, Salmo salar, is now understood, the progression of re-infection (post-treatment) required elucidation. Here, we describe the weekly histopathological progression of AGD from first to second freshwater bath. Halocline cessation and increased water temperature appeared to drive the rapid onset of initial infection prior to bathing. Freshwater bathing cleared lesions of attached trophozoites and associated cellular debris. Subsequent gill re-infection with Neoparamoeba sp. was evident at 2 weeks post-bath and had significantly increased (P < 0.001), in severity by 4 weeks post-bath. No significant difference in gross pathology was observed until 4 weeks post-bath (P < 0.05). The re-infective progression of AGD was characterized by localized host tissue responses juxtaposed to adhered trophozoites (epithelial oedema, hypertrophy and hyperplasia), non-specific inflammatory cell infiltration (macrophages, neutrophils and eosinophilic granule cells) and finally advanced hyperplasia with epithelial fortification. During the post-bath period, non-AGD lesions including haemorrhage, necrosis and regenerative hyperplasia were occasionally observed, although no evidence of secondary colonization of these lesions by Neoparamoeba sp. was noted. We conclude that pathogenesis during the inter-bath period was identical to initial infection although the source of re-infection remains to be established.

Entities:  

Mesh:

Year:  2004        PMID: 15009242     DOI: 10.1111/j.1365-2761.2004.00531.x

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  6 in total

1.  Evaluation of Low Temperature and Salinity as a Treatment of Atlantic Salmon against Amoebic Gill Disease.

Authors:  Jemma Hudson; Mark Adams; Khattapan Jantawongsri; Tim Dempster; Barbara F Nowak
Journal:  Microorganisms       Date:  2022-01-18

2.  Transcriptome analyses of amoebic gill disease-affected Atlantic salmon (Salmo salar) tissues reveal localized host gene suppression.

Authors:  James W Wynne; Maree G O'Sullivan; Mathew T Cook; Glenn Stone; Barbara F Nowak; David R Lovell; Nicholas G Elliott
Journal:  Mar Biotechnol (NY)       Date:  2008-01-25       Impact factor: 3.619

3.  Development of an in vitro model system for studying bacterially expressed dsRNA-mediated knockdown in Neoparamoeba genus.

Authors:  Paula C Lima; Natasha A Botwright; James O Harris; Mathew Cook
Journal:  Mar Biotechnol (NY)       Date:  2014-02-09       Impact factor: 3.619

4.  Comparative proteomic profiling of newly acquired, virulent and attenuated Neoparamoeba perurans proteins associated with amoebic gill disease.

Authors:  Kerrie Ní Dhufaigh; Eugene Dillon; Natasha Botwright; Anita Talbot; Ian O'Connor; Eugene MacCarthy; Orla Slattery
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

5.  Differential Exoproteome and Biochemical Characterisation of Neoparamoeba perurans.

Authors:  Kerrie Ní Dhufaigh; Natasha Botwright; Eugene Dillon; Ian O'Connor; Eugene MacCarthy; Orla Slattery
Journal:  Microorganisms       Date:  2021-06-09

6.  Gene expression analysis of Atlantic salmon gills reveals mucin 5 and interleukin 4/13 as key molecules during amoebic gill disease.

Authors:  Mar Marcos-López; Josep A Calduch-Giner; Luca Mirimin; Eugene MacCarthy; Hamish D Rodger; Ian O'Connor; Ariadna Sitjà-Bobadilla; Jaume Pérez-Sánchez; M Carla Piazzon
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.